Quanterix Corporation (QTRX): Price and Financial Metrics


Quanterix Corporation (QTRX): $16.61

0.04 (+0.24%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

QTRX POWR Grades


  • Sentiment is the dimension where QTRX ranks best; there it ranks ahead of 74.75% of US stocks.
  • QTRX's strongest trending metric is Momentum; it's been moving down over the last 179 days.
  • QTRX ranks lowest in Growth; there it ranks in the 11th percentile.

QTRX Stock Summary

  • QTRX's price/sales ratio is 9.71; that's higher than the P/S ratio of 84.85% of US stocks.
  • Equity multiplier, or assets relative to shareholders' equity, comes in at 1.13 for Quanterix Corp; that's greater than it is for only 9.78% of US stocks.
  • With a year-over-year growth in debt of -30.78%, Quanterix Corp's debt growth rate surpasses only 13.42% of about US stocks.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Quanterix Corp are NVVE, IMMR, AUPH, CNTG, and CASI.
  • Visit QTRX's SEC page to see the company's official filings. To visit the company's web site, go to www.quanterix.com.

QTRX Valuation Summary

  • In comparison to the median Healthcare stock, QTRX's price/sales ratio is 48.9% higher, now standing at 16.9.
  • Over the past 45 months, QTRX's EV/EBIT ratio has gone down 36.7.
  • QTRX's price/sales ratio has moved up 1.5 over the prior 45 months.

Below are key valuation metrics over time for QTRX.

Stock Date P/S P/B P/E EV/EBIT
QTRX 2021-08-31 16.9 4.0 -62.9 -50.0
QTRX 2021-08-30 16.7 3.9 -61.9 -49.0
QTRX 2021-08-27 16.7 3.9 -62.0 -49.1
QTRX 2021-08-26 15.2 3.6 -56.7 -43.7
QTRX 2021-08-25 16.8 4.0 -62.4 -49.5
QTRX 2021-08-24 17.0 4.0 -63.4 -50.5

QTRX's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • QTRX has a Quality Grade of D, ranking ahead of 13.4% of graded US stocks.
  • QTRX's asset turnover comes in at 0.276 -- ranking 59th of 75 Measuring and Control Equipment stocks.
  • 500 - Internal server error

The table below shows QTRX's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.276 0.603 -0.474
2021-03-31 0.318 0.590 -0.489
2020-12-31 0.398 0.558 -0.511
2020-09-30 0.397 0.525 -0.611
2020-06-30 0.352 0.434 -1.038
2020-03-31 0.385 0.460 -1.276

QTRX Price Target

For more insight on analysts targets of QTRX, see our QTRX price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $76.00 Average Broker Recommendation 1.42 (Moderate Buy)

QTRX Stock Price Chart Interactive Chart >

Price chart for QTRX

QTRX Price/Volume Stats

Current price $16.61 52-week high $69.22
Prev. close $16.57 52-week low $14.86
Day low $16.00 Volume 310,400
Day high $16.95 Avg. volume 322,889
50-day MA $24.09 Dividend yield N/A
200-day MA $37.58 Market Cap 613.08M

Quanterix Corporation (QTRX) Company Bio


Quanterix Corporation develops and markets ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and Asia Pacific. It develops Simoa HD-1 Analyzer, a sensitive protein detection platform, which analyzes approximately six biomarkers per test; and SR-X system that supports the detection capability of approximately six biomarkers per test. The company’s products also comprise kits, such as beads, capture and detector reagents, enzyme reagents, and enzyme substrates to run tests; and consumables, such as proprietary Simoa disks, cuvettes, and disposable tips. In addition, it offers contract research services, including sample testing, assay development, and custom development services. Quanterix Corporation primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was founded in 2007 and is based in Lexington, Massachusetts.


QTRX Latest News Stream


Event/Time News Detail
Loading, please wait...

QTRX Latest Social Stream


Loading social stream, please wait...

View Full QTRX Social Stream

Latest QTRX News From Around the Web

Below are the latest news stories about Quanterix Corp that investors may wish to consider to help them evaluate QTRX as an investment opportunity.

Quanterix Corporation to Release Fourth Quarter and Full Year 2021 Financial Results on March 1, 2022

BILLERICA, Mass., February 23, 2022--Quanterix Corporation to Release Fourth Quarter and Full Year 2021 Financial Results on March 1, 2022

Yahoo | February 23, 2022

Quanterix to Participate in the SVB Leerink Global Healthcare Conference

BILLERICA, Mass., February 09, 2022--Quanterix to Participate in the SVB Leerink Global Healthcare Conference

Yahoo | February 9, 2022

UK Dementia Research Institute Biomarker Factory Powers Alzheimer’s Disease Breakthroughs with Quanterix Simoa® Technology

BILLERICA, Mass., February 07, 2022--UK Dementia Research Institute Biomarker Factory Powers Alzheimer’s Disease Breakthroughs with Quanterix Simoa® Technology

Yahoo | February 7, 2022

Quanterix’ Simoa® Technology Powers Latest Breakthrough in Epstein-Barr Virus and Multiple Sclerosis

BILLERICA, Mass., January 26, 2022--Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced its Simoa® technology was instrumental in revealing high prevalence of Epstein-Barr virus (EBV) associated with multiple sclerosis (MS), according to a recent study published in the journal Science. Principal Investigator, Dr. Albert Ascherio, epidemiologist at the Harvard T.H. Chan School of Public Health, i

Yahoo | January 26, 2022

Quanterix sees Q4 and FY 2021 revenue above consensus

Quanterix (QTRX) provides preliminary financial highlights for Q4 and FY 2021 ending December 31, 2021

Seeking Alpha | January 13, 2022

Read More 'QTRX' Stories Here

QTRX Price Returns

1-mo -28.13%
3-mo -48.43%
6-mo -61.43%
1-year -67.64%
3-year -25.62%
5-year N/A
YTD -60.83%
2021 -8.82%
2020 96.78%
2019 29.06%
2018 -14.72%
2017 N/A

Continue Researching QTRX

Want to see what other sources are saying about Quanterix Corp's financials and stock price? Try the links below:

Quanterix Corp (QTRX) Stock Price | Nasdaq
Quanterix Corp (QTRX) Stock Quote, History and News - Yahoo Finance
Quanterix Corp (QTRX) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.5354 seconds.